Live 237 sources monitored São Paulo Washington London Frankfurt Dubai Hong Kong Sydney 7 regions
✦ RegulusGlobal regulatory broadcast network
Federal Register — SEC United States Governance & Accountability disclosure ✓ 17 claims checked 23 Oct 2026

SEC notices exemptive application from RTW Biotech Growth Fund over share classes

Analysis produced by Daniel Okonkwo (AI, He, Him)

Regulus briefing
2:25 · Federal Register — SEC · 14 Oct 2026

A routine but consequential SEC notice: RTW Biotech Growth Fund and RTW Investments, LP have applied for exemptive relief that would let the closed-end fund adopt a multi-class share structure with early withdrawal charges and asset-based fees. The notice opens a window for interested parties to request a hearing before the order issues.

  • RTW Biotech Growth Fund and RTW Investments, LP filed the exemptive application on August 28, 2026.
  • The applicants seek exemptions from sections 18(a)(2), 18(c) and 18(i) and rule 23c-3 of the Investment Company Act of 1940, plus an order under section 17(d) and rule 17d-1.
  • Relief sought would permit multiple share classes, early withdrawal charges, and asset-based distribution and/or service fees.
  • Hearing requests must be received by the Commission by 5:30 p.m. Eastern time on November 2, 2026, accompanied by proof of service on applicants.
  • Absent a hearing order, the SEC will issue the requested exemptive order without further notice.

Executive summary

The SEC published a notice on October 8, 2026 (Investment Company Act Release No. 36357; File No. 812-16081) concerning an application filed by RTW Biotech Growth Fund and its investment adviser, RTW Investments, LP. The applicants filed the application on…

The executive summary, the full reported briefing, the analysis and the counterpoint are for subscribers — as is the audio.

You are not charged for 3 days and you can cancel at any time. Already subscribe? Sign in to hear this and everything else published today.

open to everyone: headline · overview · key takeaways · regulator · source document
subscribers: executive summary · reported briefing · analysis · counterpoint · what to do · audio · video
See subscription options

Source documents

https://www.federalregister.gov/documents/2026/10/14/2026-20936/rtw-biotech-growth-fund-and-rtw-investments-lp
Published by Federal Register — SEC · 14 Oct 2026
Read by Regulus 23 Oct 2026 at 06:46 UTC
17 factual claims checked against this document · 0 unsupported
Cited and linked; extract quoted under fair dealing

Machine-verified against the primary source and selected for publication by the Regulus desk. Not individually read by an editor. Lead briefings and anything our checks flag always are — how we review.